Summary statistics [mean (
Toxicant . | CASRN . | CSF set I (mg/kg-d)−1 . | R . | . | Lt . | . | ULt . | . | PREP . | . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | ||||||||||
Acetaldehyde | 75-07-0 | 0.0077* | 6e−05 | 6e−06 | 5e−05 | 6e−06 | 3e−05 | 1e−05 | 4e−06 | 4e−06 | ||||||||||
Acrylonitrile | 107-13-1 | 0.24* | 3e−05 | 6e−06 | 3e−05 | 8e−06 | 2e−05 | 7e−06 | 4e−06 | 3e−06 | ||||||||||
4-Aminobiphenyl | 92-67-1 | 21† | 5e−07 | 9e−08 | 4e−07 | 4e−08 | 2e−07 | 6e−08 | 2e−07 | 9e−08 | ||||||||||
Arsenic | 7440-38-2 | 15* | 9e−07 | 3e−07 | 7e−07 | 2e−07 | 4e−07 | 2e−07 | 2e−08 | NA‡ | ||||||||||
Benzene | 71-43-2 | 0.027* | 9e−06 | 1e−06 | 9e−06 | 1e−06 | 6e−06 | 2e−06 | 1e−06 | 1e−06 | ||||||||||
Benzo[a]pyrene | 50-32-8 | 3.9† | 5e−07 | 8e−08 | 4e−07 | 5e−08 | 2e−07 | 6e−08 | 4e−08 | 5e−08 | ||||||||||
1,3-Butadiene | 106-99-0 | 0.11* | 4e−05 | 7e−06 | 4e−05 | 8e−06 | 2e−05 | 8e−06 | 5e−06 | 5e−06 | ||||||||||
Cadmium | 7440-43-9 | 6.3* | 5e−06 | 7e−07 | 3e−06 | 6e−07 | 2e−06 | 7e−07 | 3e−07 | 2e−07 | ||||||||||
Formaldehyde | 50-00-0 | 0.046* | 2e−05 | 3e−06 | 1e−05 | 4e−06 | 5e−06 | 2e−06 | 2e−06 | 2e−06 | ||||||||||
Lead | 7439-92-1 | 0.042† | 1e−08 | 2e−09 | 1e−08 | 2e−09 | 5e−09 | 2e−09 | 3e−09 | 1e−10 | ||||||||||
NNK§ | 64091-91-4 | 49∥ | 4e−05 | 5e−06 | 3e−05 | 5e−06 | 2e−05 | 6e−06 | 4e−06 | 7e−07 | ||||||||||
N-Nitrosonornicotine | 80508-23-2 | 1.4† | 2e−06 | 3e−07 | 1e−06 | 3e−07 | 8e−07 | 3e−07 | 1e−07 | 6e−08 | ||||||||||
Quinoline§ | 91-22-5 | 3* | 2e−05 | 8e−06 | 1e−05 | 4e−06 | 7e−06 | 2e−06 | 2e−06 | 1e−06 | ||||||||||
Cancer risk subtotals | ||||||||||||||||||||
Human lung carcinogens*,¶ \(\overline{\mathrm{ILCR}}_{1}^{\mathrm{sub{\Sigma}{-}lung}}\) | 5e−05 | 1e−05 | 4e−05 | 1e−05 | 2e−05 | 9e−06 | 4e−06 | 5e−06 | ||||||||||||
All cancers: \(\overline{\mathrm{ILCR}}_{1}^{\mathrm{sub{\Sigma}}}\) | 2e−04 | 2e−05 | 2e−04 | 3e−05 | 1e−04 | 3e−05 | 2e−05 | 2e−05 |
Toxicant . | CASRN . | CSF set I (mg/kg-d)−1 . | R . | . | Lt . | . | ULt . | . | PREP . | . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | \(\overline{\mathrm{ILCR}}_{1}^{\mathit{i}}\)
. | SD . | ||||||||||
Acetaldehyde | 75-07-0 | 0.0077* | 6e−05 | 6e−06 | 5e−05 | 6e−06 | 3e−05 | 1e−05 | 4e−06 | 4e−06 | ||||||||||
Acrylonitrile | 107-13-1 | 0.24* | 3e−05 | 6e−06 | 3e−05 | 8e−06 | 2e−05 | 7e−06 | 4e−06 | 3e−06 | ||||||||||
4-Aminobiphenyl | 92-67-1 | 21† | 5e−07 | 9e−08 | 4e−07 | 4e−08 | 2e−07 | 6e−08 | 2e−07 | 9e−08 | ||||||||||
Arsenic | 7440-38-2 | 15* | 9e−07 | 3e−07 | 7e−07 | 2e−07 | 4e−07 | 2e−07 | 2e−08 | NA‡ | ||||||||||
Benzene | 71-43-2 | 0.027* | 9e−06 | 1e−06 | 9e−06 | 1e−06 | 6e−06 | 2e−06 | 1e−06 | 1e−06 | ||||||||||
Benzo[a]pyrene | 50-32-8 | 3.9† | 5e−07 | 8e−08 | 4e−07 | 5e−08 | 2e−07 | 6e−08 | 4e−08 | 5e−08 | ||||||||||
1,3-Butadiene | 106-99-0 | 0.11* | 4e−05 | 7e−06 | 4e−05 | 8e−06 | 2e−05 | 8e−06 | 5e−06 | 5e−06 | ||||||||||
Cadmium | 7440-43-9 | 6.3* | 5e−06 | 7e−07 | 3e−06 | 6e−07 | 2e−06 | 7e−07 | 3e−07 | 2e−07 | ||||||||||
Formaldehyde | 50-00-0 | 0.046* | 2e−05 | 3e−06 | 1e−05 | 4e−06 | 5e−06 | 2e−06 | 2e−06 | 2e−06 | ||||||||||
Lead | 7439-92-1 | 0.042† | 1e−08 | 2e−09 | 1e−08 | 2e−09 | 5e−09 | 2e−09 | 3e−09 | 1e−10 | ||||||||||
NNK§ | 64091-91-4 | 49∥ | 4e−05 | 5e−06 | 3e−05 | 5e−06 | 2e−05 | 6e−06 | 4e−06 | 7e−07 | ||||||||||
N-Nitrosonornicotine | 80508-23-2 | 1.4† | 2e−06 | 3e−07 | 1e−06 | 3e−07 | 8e−07 | 3e−07 | 1e−07 | 6e−08 | ||||||||||
Quinoline§ | 91-22-5 | 3* | 2e−05 | 8e−06 | 1e−05 | 4e−06 | 7e−06 | 2e−06 | 2e−06 | 1e−06 | ||||||||||
Cancer risk subtotals | ||||||||||||||||||||
Human lung carcinogens*,¶ \(\overline{\mathrm{ILCR}}_{1}^{\mathrm{sub{\Sigma}{-}lung}}\) | 5e−05 | 1e−05 | 4e−05 | 1e−05 | 2e−05 | 9e−06 | 4e−06 | 5e−06 | ||||||||||||
All cancers: \(\overline{\mathrm{ILCR}}_{1}^{\mathrm{sub{\Sigma}}}\) | 2e−04 | 2e−05 | 2e−04 | 3e−05 | 1e−04 | 3e−05 | 2e−05 | 2e−05 |
NOTE: Conventional cigarettes classified by FTC tar yield as follows (30): regular, tar ≥ 15.0 mg; light, 6.0 mg ≤ tar < 15.0 mg; and ultralight, 1.0 ≤ tar < 6.0 mg. PREP cigarettes not characterized by tar content.
Abbreviation: CASRN, Chemical Abstracts Registry Number.
Integrated Risk Information System, U.S. Environmental Protection Agency (44).
Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. Sept. 2004 Cancer Potency List (46).
NA, not available; limited PREP yield data did not allow calculations for some chemicals. The mean (
CSF was determined from an oral exposure study.
CSF, 49 for all cancer end points. California Environmental Protection Agency. Sept. 2001 Expedited Cancer Potency Values and No Significant Risk Levels for Six Proposition 65 Carcinogens (47).